PlatoScience
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PlatoScience - overview
Established
2015
Location
Copenhagen, -, Denmark
Primary Industry
Electronics
About
PlatoScience develops advanced neurotechnology solutions, notably the PlatoWork tDCS headset, which enhances cognitive function through transcranial Direct Current Stimulation, catering to both clinical and personal use. Founded in 2015, PlatoScience is based in Copenhagen, Denmark. The company specializes in neurotechnology solutions, including devices for cognitive enhancement. Balder Onarheim serves as CEO, having founded the company alongside Morten Friis-Olivarius.
In January 2022, PlatoScience raised DKK 1. 000 mn from investors KICKASS Capital and others, totaling DKK 1. 000 mn raised through three deals to date. PlatoScience specializes in advanced neurotechnology solutions, primarily their PlatoWork tDCS headset, which utilizes transcranial Direct Current Stimulation for cognitive enhancement.
The headset includes three programmable electrodes and remote monitoring capabilities, allowing clinicians to monitor treatment protocols effectively. Targeted towards clinicians, researchers, and individuals aiming to enhance cognitive performance, PlatoScience’s products are distributed across various international markets, including Europe, North America, and select regions in Asia. In 2016, PlatoScience reported a revenue of DKK 1,575. 1 mn and an EBITDA of DKK 401,085.
4 in 2023. The company generates revenue through the sale of tDCS devices and certification programs for clinicians, operating on a B2B and B2C model. Clinicians purchase the PlatoWork headset directly or via distributors, while training programs enhance the application of tDCS technology in clinical settings. PlatoScience is focused on expanding its product line and geographic reach.
The company plans to introduce new products designed for cognitive enhancement, with specific release dates yet to be announced. Additionally, they aim to enter new markets across Europe and Asia by the end of 2023, utilizing funds raised in January 2022 to support these initiatives, particularly in product development and market expansion.
Current Investors
KICKASS Capital, Btomorrow Ventures, ES Holding ApS
Primary Industry
Electronics
Sub Industries
Electronic Components, Engineering Software
Website
www.platoscience.com
Verticals
Mobile Apps
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
PlatoScience - financials
| Fiscal Year Ended | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | 10,595 | - | - | - | - | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | (23,713) | 942 | (396,069) | (1,072,529) | (302,941) | (1,404,227) | (1,907,834) | - | - | - |
| Operating Income (USD) | (23,713) | 942 | (433,372) | (1,072,529) | (459,312) | (2,196,169) | (2,712,020) | - | - | - |
| Operating Margin | - | 8.9% | - | - | - | - | - | - | - | - |
| % EBITDA Margin | - | 8.9% | - | - | - | - | - | - | - | - |
| NET Income (USD) | (17,796) | 942 | (401,066) | (782,427) | (468,470) | (2,514,268) | (1,594,419) | - | - | - |
| % Net Margin | - | 8.9% | - | - | - | - | - | - | - | - |
PlatoScience - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.